{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:00:19Z","timestamp":1791687619044,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070780"],"award-info":[{"award-number":["82070780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The pathogenesis of benign prostatic hyperplasia (BPH) has not been fully elucidated. Ras homology family member A (RhoA) plays an important role in regulating cell cytoskeleton, growth and fibrosis. The role of RhoA in BPH remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study aimed to clarify the expression, functional activity and mechanism of RhoA in BPH. Human prostate tissues, human prostate cell lines, BPH rat model were used. Cell models of RhoA knockdown and overexpression were generated. Immunofluorescence staining, quantitative real time PCR (qRT-PCR), Western blotting, cell counting kit-8 (CCK-8), flow cytometry, phalloidine staining, organ bath study, gel contraction assay, protein stability analysis, isolation and extraction of nuclear protein and cytoplasmic protein were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study we found that RhoA was localized in prostate stroma and epithelial compartments and was up-regulated in both BPH patients and BPH rats. Functionally, RhoA knockdown induced cell apoptosis and inhibited cell proliferation, fibrosis, epithelial-mesenchymal transformation (EMT) and contraction. Consistently, overexpression of RhoA reversed all aforementioned processes. More importantly, we found that \u03b2-catenin and the downstream of Wnt\/\u03b2-catenin signaling, including C-MYC, Survivin and Snail were up-regulated in BPH rats. Downregulation of RhoA significantly reduced the expression of these proteins. Rho kinase inhibitor\u00a0Y-27632 also down-regulated \u03b2-catenin protein in a concentration-dependent manner. However, overexpression of \u03b2-catenin did not affect RhoA-ROCK levels, suggesting that \u03b2-catenin was the\u00a0downstream of RhoA-ROCK regulation. Further data suggested that RhoA increased nuclear translocation of \u03b2-catenin and up-regulated \u03b2-catenin expression by inhibiting its proteasomal degradation, thereby activating Wnt\/\u03b2-catenin signaling. Overexpression of \u03b2-catenin partially reversed the changes in cell growth, fibrosis and EMT except cell contraction caused by RhoA downregulation. Finally, Y-27632 partially reversed prostatic hyperplasia in vivo, further suggesting the potential of RhoA-ROCK signaling in BPH treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our novel data demonstrated that RhoA regulated both static and dynamic factors of BPH, RhoA-ROCK-\u03b2-catenin signaling axis played an important role in the development of BPH and might provide more possibilities for the formulation of subsequent clinical treatment strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-023-00734-2","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T14:01:51Z","timestamp":1697810511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-\u03b2-catenin signaling axis and static &amp; dynamic dual roles"],"prefix":"10.1186","volume":"29","author":[{"given":"Shidong","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"DiSanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-428X","authenticated-orcid":false,"given":"Xinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"734_CR1","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1073\/pnas.0812666106","volume":"106","author":"P Alonso-Magdalena","year":"2009","unstructured":"Alonso-Magdalena P, Brossner C, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci U S A. 2009;106:2859\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"734_CR2","doi-asserted-by":"crossref","first-page":"R570","DOI":"10.1016\/j.cub.2018.03.045","volume":"28","author":"A Basant","year":"2018","unstructured":"Basant A, Glotzer M. Spatiotemporal regulation of RhoA during cytokinesis. Curr Biol. 2018;28:R570\u201380.","journal-title":"Curr Biol"},{"key":"734_CR3","first-page":"313","volume":"2","author":"TM Bauman","year":"2014","unstructured":"Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA. Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue. Am J Clin Exp Urol. 2014;2:313\u201322.","journal-title":"Am J Clin Exp Urol"},{"key":"734_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474\u20139.","journal-title":"J Urol"},{"key":"734_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1242\/jcs.03428","volume":"120","author":"RJ Buchsbaum","year":"2007","unstructured":"Buchsbaum RJ. Rho activation at a glance. J Cell Sci. 2007;120:1149\u201352.","journal-title":"J Cell Sci"},{"key":"734_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pros.2990110405","volume":"11","author":"R Buttyan","year":"1987","unstructured":"Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA. Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers. Prostate. 1987;11:327\u201337.","journal-title":"Prostate"},{"key":"734_CR7","volume":"104","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen F, Xu F, Wang K, Zhang K, Li G, Chen J, Deng H, He Q. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin alpha8-mediated activation of RhoA signaling pathway. Metab Clin Exp. 2020;104: 154140.","journal-title":"Metab Clin Exp"},{"key":"734_CR8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.4103\/0366-6999.238145","volume":"131","author":"SY Chen","year":"2018","unstructured":"Chen SY, Du Y, Song J. MicroRNA-340 inhibits epithelial-mesenchymal transition by impairing ROCK-1-dependent Wnt\/beta-catenin signaling pathway in epithelial cells from human benign prostatic hyperplasia. Chin Med J (engl). 2018;131:2008\u201312.","journal-title":"Chin Med J (engl)"},{"key":"734_CR9","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016;2:16031.","journal-title":"Nat Rev Dis Primers"},{"key":"734_CR10","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.00384","volume":"116","author":"BW Doble","year":"2003","unstructured":"Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003;116:1175\u201386.","journal-title":"J Cell Sci"},{"key":"734_CR11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0960-9822(00)00645-X","volume":"10","author":"M Fanto","year":"2000","unstructured":"Fanto M, Weber U, Strutt DI, Mlodzik M. Nuclear signaling by Rac and Rho GTPases is required in the establishment of epithelial planar polarity in the Drosophila eye. Curr Biol. 2000;10:979\u201388.","journal-title":"Curr Biol"},{"key":"734_CR12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.eururo.2011.06.037","volume":"60","author":"M Gacci","year":"2011","unstructured":"Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2011;60:809\u201325.","journal-title":"Eur Urol"},{"key":"734_CR13","doi-asserted-by":"crossref","first-page":"11641","DOI":"10.1074\/jbc.M411781200","volume":"280","author":"C Gajate","year":"2005","unstructured":"Gajate C, Mollinedo F. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy. J Biol Chem. 2005;280:11641\u20137.","journal-title":"J Biol Chem"},{"key":"734_CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0092-8674(01)00614-6","volume":"107","author":"R Habas","year":"2001","unstructured":"Habas R, Kato Y, He X. Wnt\/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell. 2001;107:843\u201354.","journal-title":"Cell"},{"key":"734_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/CS20201283","volume":"135","author":"W He","year":"2021","unstructured":"He W, Wang X, Zhan D, Li M, Wang Q, Liu J, Liu D, Fu X, Qian Q, Li Y, Chen P, Zeng G, Wang X, DiSanto ME, Zhang X. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate. Clin Sci (lond). 2021;135:167\u201383.","journal-title":"Clin Sci (lond)"},{"key":"734_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-824X-4-1","volume":"4","author":"GA Howe","year":"2012","unstructured":"Howe GA, Addison CL. RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA. Vasc Cell. 2012;4:1.","journal-title":"Vasc Cell"},{"key":"734_CR17","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1111\/jcmm.15689","volume":"24","author":"ZX Huang","year":"2020","unstructured":"Huang ZX, Mao XM, Wu RF, Huang SM, Ding XY, Chen QH, Chen QX. RhoA\/ROCK pathway mediates the effect of oestrogen on regulating epithelial-mesenchymal transition and proliferation in endometriosis. J Cell Mol Med. 2020;24:10693\u2013704.","journal-title":"J Cell Mol Med"},{"key":"734_CR18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol. 2005;21:247\u201369.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"734_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-063014-123902","volume":"67","author":"EH Kim","year":"2016","unstructured":"Kim EH, Larson JA, Andriole GL. Management of benign prostatic hyperplasia. Annu Rev Med. 2016;67:137\u201351.","journal-title":"Annu Rev Med"},{"key":"734_CR20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/jcp.25572","volume":"232","author":"JG Kim","year":"2017","unstructured":"Kim JG, Kim MJ, Choi WJ, Moon MY, Kim HJ, Lee JY, Kim J, Kim SC, Kang SG, Seo GY, Kim PH, Park JB. Wnt3A induces GSK-3beta phosphorylation and beta-catenin accumulation through RhoA\/ROCK. J Cell Physiol. 2017a;232:1104\u201313.","journal-title":"J Cell Physiol"},{"key":"734_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2016.12.013","volume":"103","author":"JG Kim","year":"2017","unstructured":"Kim JG, Kwon HJ, Wu G, Park Y, Lee JY, Kim J, Kim SC, Choe M, Kang SG, Seo GY, Kim PH, Park JB. RhoA GTPase oxidation stimulates cell proliferation via nuclear factor-kappaB activation. Free Radic Biol Med. 2017b;103:57\u201368.","journal-title":"Free Radic Biol Med"},{"key":"734_CR22","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.18632\/aging.202242","volume":"13","author":"Y Kim","year":"2021","unstructured":"Kim Y, Lee D, Jo H, Go C, Yang J, Kang D, Kang JS. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition. Aging (albany NY). 2021;13:3202\u201317.","journal-title":"Aging (albany NY)."},{"key":"734_CR23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/rcmb.2017-0075OC","volume":"58","author":"RS Knipe","year":"2018","unstructured":"Knipe RS, Probst CK, Lagares D, Franklin A, Spinney JJ, Brazee PL, Grasberger P, Zhang L, Black KE, Sakai N, Shea BS, Liao JK, Medoff BD, Tager AM. The rho kinase isoforms ROCK1 and ROCK2 each contribute to the development of experimental pulmonary fibrosis. Am J Respir Cell Mol Biol. 2018;58:471\u201381.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"734_CR24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.juro.2012.08.220","volume":"189","author":"M Lam","year":"2013","unstructured":"Lam M, Kerr KP, Exintaris B. Involvement of Rho-kinase signaling pathways in nerve evoked and spontaneous contractions of the Guinea pig prostate. J Urol. 2013;189:1147\u201354.","journal-title":"J Urol"},{"key":"734_CR25","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1128\/MCB.16.10.5313","volume":"16","author":"T Leung","year":"1996","unstructured":"Leung T, Chen XQ, Manser E, Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Bio. 1996;16:5313\u201327.","journal-title":"Mol Cell Bio"},{"key":"734_CR26","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.7150\/thno.35665","volume":"9","author":"S Li","year":"2019","unstructured":"Li S, Li C, Zhang Y, He X, Chen X, Zeng X, Liu F, Chen Y, Chen J. Targeting mechanics-induced fibroblast activation through cd44-rhoa-yap pathway ameliorates crystalline silica-induced silicosis. Theranostics. 2019;9:4993\u20135008.","journal-title":"Theranostics"},{"key":"734_CR27","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.3892\/mmr.2017.6545","volume":"15","author":"D Liu","year":"2017","unstructured":"Liu D, Mei X, Wang L, Yang X. RhoA inhibits apoptosis and increases proliferation of cultured SPCA1 lung cancer cells. Mol Med Rep. 2017;15:3963\u20138.","journal-title":"Mol Med Rep"},{"key":"734_CR28","volume":"106","author":"J Liu","year":"2023","unstructured":"Liu J, Liu D, Zhang J, He W, Guo Y, Li Y, Chen P, DiSanto ME, Zhang X. Expression and functional activity of myosin II in hyperplastic prostates of varying volumes. Cell Signal. 2023;106: 110658.","journal-title":"Cell Signal"},{"key":"734_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0092-8674(85)90058-3","volume":"41","author":"P Madaule","year":"1985","unstructured":"Madaule P, Axel R. A novel ras-related gene family. Cell. 1985;41:31\u201340.","journal-title":"Cell"},{"key":"734_CR30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000496289","volume":"65","author":"S Madersbacher","year":"2019","unstructured":"Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology. 2019;65:458\u201364.","journal-title":"Gerontology"},{"key":"734_CR31","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/j.1460-2075.1996.tb00574.x","volume":"15","author":"T Matsui","year":"1996","unstructured":"Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996;15:2208\u201316.","journal-title":"EMBO J"},{"key":"734_CR32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrurol.2017.144","volume":"14","author":"V Murillo-Garzon","year":"2017","unstructured":"Murillo-Garzon V, Kypta R. WNT signalling in prostate cancer. Nat Rev Urol. 2017;14:683\u201396.","journal-title":"Nat Rev Urol"},{"key":"734_CR33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12253-008-9077-1","volume":"15","author":"B Nagy","year":"2009","unstructured":"Nagy B, Szendroi A, Romics I. Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy. Pathol Oncol Res. 2009;15:279\u201383.","journal-title":"Pathol Oncol Res"},{"key":"734_CR34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.stem.2010.06.018","volume":"7","author":"M Ohgushi","year":"2010","unstructured":"Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, Nishiyama A, Muguruma K, Nakano T, Suga H, Ueno M, Ishizaki T, Suemori H, Narumiya S, Niwa H, Sasai Y. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell. 2010;7:225\u201339.","journal-title":"Cell Stem Cell"},{"key":"734_CR35","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.yexcr.2008.07.012","volume":"314","author":"N Papadopoulou","year":"2008","unstructured":"Papadopoulou N, Charalampopoulos I, Alevizopoulos K, Gravanis A, Stournaras C. Rho\/ROCK\/actin signaling regulates membrane androgen receptor induced apoptosis in prostate cancer cells. Exp Cell Res. 2008;314:3162\u201374.","journal-title":"Exp Cell Res"},{"key":"734_CR36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/pros.20896","volume":"69","author":"G Penna","year":"2009","unstructured":"Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E, Chavalmane A, Morelli A, Sarchielli E, Vannelli GB, Gacci M, Colli E, Maggi M, Adorini L. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA\/Rho kinase and NF-kappaB pathways. Prostate. 2009;69:480\u201393.","journal-title":"Prostate"},{"key":"734_CR37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.juro.2012.03.125","volume":"188","author":"EA Platz","year":"2012","unstructured":"Platz EA, Joshu CE, Mondul AM, Peskoe SB, Willett WC, Giovannucci E. Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. J Urol. 2012;188:496\u2013501.","journal-title":"J Urol"},{"key":"734_CR38","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/01.ju.0000085024.47406.6c","volume":"170","author":"RW Rees","year":"2003","unstructured":"Rees RW, Foxwell NA, Ralph DJ, Kell PD, Moncada S, Cellek S. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J Urol. 2003;170:2517\u201322.","journal-title":"J Urol"},{"key":"734_CR39","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nrurol.2013.149","volume":"10","author":"JA Rodriguez-Nieves","year":"2013","unstructured":"Rodriguez-Nieves JA, Macoska JA. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 2013;10:546\u201350.","journal-title":"Nat Rev Urol"},{"key":"734_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrm1587","volume":"6","author":"KL Rossman","year":"2005","unstructured":"Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol. 2005;6:167\u201380.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"734_CR41","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.trecan.2022.04.005","volume":"8","author":"A Schaefer","year":"2022","unstructured":"Schaefer A, Der CJ. RHOA takes the RHOad less traveled to cancer. Trends Cancer. 2022;8:655\u201369.","journal-title":"Trends Cancer"},{"key":"734_CR42","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/01.ju.0000176459.79180.d1","volume":"174","author":"SF Shariat","year":"2005","unstructured":"Shariat SF, Ashfaq R, Roehrborn CG, Slawin KM, Lotan Y. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J Urol. 2005;174:2046\u201350.","journal-title":"J Urol"},{"key":"734_CR43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13619-020-00071-3","volume":"10","author":"W Shi","year":"2021","unstructured":"Shi W, Xu C, Gong Y, Wang J, Ren Q, Yan Z, Mei L, Tang C, Ji X, Hu X, Qv M, Hussain M, Zeng LH, Wu X. RhoA\/Rock activation represents a new mechanism for inactivating Wnt\/beta-catenin signaling in the aging-associated bone loss. Cell Regen. 2021;10:8.","journal-title":"Cell Regen"},{"key":"734_CR44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.115.306532","volume":"118","author":"H Shimokawa","year":"2016","unstructured":"Shimokawa H, Sunamura S, Satoh K. RhoA\/Rho-kinase in the cardiovascular system. Circ Res. 2016;118:352\u201366.","journal-title":"Circ Res"},{"key":"734_CR45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bju.12745","volume":"115","author":"M Speakman","year":"2015","unstructured":"Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int. 2015;115:508\u201319.","journal-title":"BJU Int"},{"key":"734_CR46","doi-asserted-by":"crossref","first-page":"15320","DOI":"10.1074\/jbc.M510954200","volume":"281","author":"T Tanaka","year":"2006","unstructured":"Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, Nishida H, Kaibuchi K, Hamamori Y. Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Bio Chem. 2006;281:15320\u20139.","journal-title":"J Bio Chem."},{"key":"734_CR47","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/emboj.2008.9","volume":"27","author":"K Tanegashima","year":"2008","unstructured":"Tanegashima K, Zhao H, Dawid IB. WGEF activates Rho in the Wnt-PCP pathway and controls convergent extension in Xenopus gastrulation. EMBO J. 2008;27:606\u201317.","journal-title":"EMBO J"},{"key":"734_CR48","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/1541-7786.MCR-19-0889","volume":"18","author":"DE Tang","year":"2020","unstructured":"Tang DE, Dai Y, Fan LL, Geng XY, Fu DX, Jiang HW, Xu SH. Histone demethylase JMJD1A promotes tumor progression via activating snail in prostate cancer. Mol Cancer Res. 2020;18:698\u2013708.","journal-title":"Mol Cancer Res"},{"key":"734_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/BC20060086","volume":"99","author":"J Tcherkezian","year":"2007","unstructured":"Tcherkezian J, Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol Cell. 2007;99:67\u201386.","journal-title":"Biol Cell"},{"key":"734_CR50","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.7150\/thno.58729","volume":"11","author":"MJ Wu","year":"2021","unstructured":"Wu MJ, Chen CJ, Lin TY, Liu YY, Tseng LL, Cheng ML, Chuu CP, Tsai HK, Kuo WL, Kung HJ, Wang WC. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. Theranostics. 2021;11:7779\u201396.","journal-title":"Theranostics"},{"key":"734_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4056d03c-20ed-4eca-9568-3e9400e2312e","volume":"6","author":"L Zhang","year":"2011","unstructured":"Zhang L, Valdez JM, Zhang B, Wei L, Chang J, Xin L. ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem\/progenitor cells and increases their cloning efficiency. PLoS ONE. 2011;6: e18271.","journal-title":"PLoS ONE"},{"key":"734_CR52","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/onc.2013.505","volume":"33","author":"C Zhang","year":"2014","unstructured":"Zhang C, Zhang S, Zhang Z, He J, Xu Y, Liu S. ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc. Oncogene. 2014;33:5582\u201391.","journal-title":"Oncogene"},{"key":"734_CR53","first-page":"391","volume":"18","author":"G Zhang","year":"2018","unstructured":"Zhang G, Zhu F, Han G, Li Z, Yu Q, Li Z, Li J. Silencing of URG11 expression inhibits the proliferation and epithelialmesenchymal transition in benign prostatic hyperplasia cells via the RhoA\/ROCK1 pathway. Mol Med Rep. 2018;18:391\u20138.","journal-title":"Mol Med Rep"},{"key":"734_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.01.106","volume":"546","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zhang M, Li Q, Yang Y, Shang Z, Luo J. TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK\/GSK3beta\/SNAIL pathway. Biochem Biophys Res Commun. 2021;546:1\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"734_CR55","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.onc.1210790","volume":"27","author":"S Zhu","year":"2008","unstructured":"Zhu S, Korzh V, Gong Z, Low BC. RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek\/Erk pathway. Oncogene. 2008;27:1580\u20139.","journal-title":"Oncogene"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-023-00734-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-023-00734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T02:26:39Z","timestamp":1700619999000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-023-00734-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["734"],"URL":"https:\/\/doi.org\/10.1186\/s10020-023-00734-2","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Collection and treatment of all human specimens were carried out in accordance with the approved guidelines of the Ethics Committee at Zhongnan Hospital of Wuhan University. All animal protocols were approved by the Medical Ethics Committee for Experimental animals of Zhongnan Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there were no competing interests associated with the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}